Werhner Pharmaceutical is a privately owned company. Established in 2001, Werhner is a research-based bio-pharmaceutical and biotechnology company dedicated to developing, manufacturing, and marketing lifestyle enhancement and rejuvenation products. Werhner portfolio also includes an extensive product line created to assist in the treatment of infertility, hypogonadisim and HIV management. We utilize various drug delivery technologies, including controlled release, trans-dermal, oral and injectable delivery systems. The Werhner brand has enjoyed a growing presence in the Asian region over the past seven year by pursuing a multi-layered growth strategy and strategic alliances with well-established partners. With offices based regionally throughout north Europe, we at Werhner are committed to ensuring we deliver the value and quality of products our patients and customers have come to expect. We are focused on continuously improving the way we do business.